RGBI Insider Trading Activity and SEC Form 4 Filings
RGBI insider trading summary
No open-market insider purchases or sales of Regen Biologics Inc (RGBI) have been reported on SEC Form 4 in the past 12 months.
Latest RGBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 9, 2008 | Robert G McNeil | Director | Buy | $5K (50,000 @ $0.10) |
| Jul 29, 2008 | William Rodkey | Vice President | Buy | $5K (50,000 @ $0.09) |
| Jul 29, 2008 | William R Timken | Director | Buy | $900 (10,000 @ $0.09) |
| Dec 12, 2007 | Russell F Warren JR | 10% Owner | Buy | $10K (150,000 @ $0.07) |
| Dec 11, 2007 | Russell F Warren JR | 10% Owner | Buy | $21K (400,000 @ $0.05) |
| Jul 9, 2007 | William Rodkey | Vice President | Buy | $4K (11,500 @ $0.38) |
| Nov 30, 2006 | William R Timken | Director | Buy | $100K (270,270 @ $0.37) |
| Nov 30, 2006 | Alan W Baldwin | Director | Buy | $10K (27,000 @ $0.37) |
| Nov 30, 2006 | John Dichiara | Sr. Vice President | Buy | $4K (10,000 @ $0.37) |
| Nov 30, 2006 | William Rodkey | Vice President | Buy | $5K (13,514 @ $0.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.